Mike Kratky
Stock Analyst at Leerink Partners
(3.14)
# 1,025
Out of 5,182 analysts
42
Total ratings
40%
Success rate
19.36%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $622 → $573 | $470.99 | +21.66% | 2 | Apr 22, 2026 | |
| BBNX Beta Bionics | Maintains: Outperform | $25 → $24 | $10.65 | +125.35% | 2 | Apr 22, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiates: Market Perform | $101 | $92.59 | +9.08% | 1 | Apr 13, 2026 | |
| SYK Stryker | Initiates: Outperform | $410 | $329.01 | +24.62% | 1 | Apr 13, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Outperform | $55 → $30 | $24.09 | +24.53% | 2 | Feb 26, 2026 | |
| PODD Insulet | Maintains: Outperform | $386 → $360 | $188.31 | +91.17% | 2 | Feb 19, 2026 | |
| TXG 10x Genomics | Maintains: Market Perform | $22 → $20 | $22.28 | -10.23% | 5 | Jan 27, 2026 | |
| PEN Penumbra | Downgrades: Market Perform | $374 | $327.98 | +14.03% | 2 | Jan 16, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $127 → $128 | $59.95 | +113.51% | 2 | Oct 1, 2025 | |
| INSP Inspire Medical Systems | Maintains: Market Perform | $116 → $97 | $55.07 | +76.14% | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $110 | $82.92 | +32.66% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $87 | $61.41 | +41.67% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $45 | $19.82 | +127.04% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $17.25 | +27.54% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $42 | $36.98 | +13.57% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $75 | $83.46 | -10.14% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $9 | $39.39 | -77.15% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $45 | $1.21 | +3,619.01% | 2 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $315 | $520.09 | -39.43% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $26 → $31 | $86.68 | -64.24% | 2 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $28.62 | -51.08% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $13.50 | +196.30% | 1 | Aug 15, 2022 |
Intuitive Surgical
Apr 22, 2026
Maintains: Outperform
Price Target: $622 → $573
Current: $470.99
Upside: +21.66%
Beta Bionics
Apr 22, 2026
Maintains: Outperform
Price Target: $25 → $24
Current: $10.65
Upside: +125.35%
Zimmer Biomet Holdings
Apr 13, 2026
Initiates: Market Perform
Price Target: $101
Current: $92.59
Upside: +9.08%
Stryker
Apr 13, 2026
Initiates: Outperform
Price Target: $410
Current: $329.01
Upside: +24.62%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Outperform
Price Target: $55 → $30
Current: $24.09
Upside: +24.53%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $386 → $360
Current: $188.31
Upside: +91.17%
10x Genomics
Jan 27, 2026
Maintains: Market Perform
Price Target: $22 → $20
Current: $22.28
Upside: -10.23%
Penumbra
Jan 16, 2026
Downgrades: Market Perform
Price Target: $374
Current: $327.98
Upside: +14.03%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $127 → $128
Current: $59.95
Upside: +113.51%
Inspire Medical Systems
Aug 15, 2025
Maintains: Market Perform
Price Target: $116 → $97
Current: $55.07
Upside: +76.14%
Jun 16, 2025
Initiates: Outperform
Price Target: $110
Current: $82.92
Upside: +32.66%
Oct 25, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $61.41
Upside: +41.67%
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $19.82
Upside: +127.04%
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $17.25
Upside: +27.54%
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $36.98
Upside: +13.57%
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $83.46
Upside: -10.14%
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $39.39
Upside: -77.15%
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $1.21
Upside: +3,619.01%
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $520.09
Upside: -39.43%
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $86.68
Upside: -64.24%
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $28.62
Upside: -51.08%
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $13.50
Upside: +196.30%